IL101172A - An enzymatic process for the preparation of AM from muanomycins - Google Patents

An enzymatic process for the preparation of AM from muanomycins

Info

Publication number: IL101172A
Authority: IL; Israel
Prior art keywords: biomass; acetone; employed; phosphate; preparation
Prior art date: 1991-03-08

Application number

IL10117292A

Other languages

English (en)

Hebrew (he)

Other versions

IL101172A0 (en

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-08

Filing date

1992-03-06

Publication date

1995-07-31

1992-03-06 Application filed by Hoechst Ag filed Critical Hoechst Ag

1992-11-15 Publication of IL101172A0 publication Critical patent/IL101172A0/xx

1995-07-31 Publication of IL101172A publication Critical patent/IL101172A/en

Links

238000000034 method Methods 0.000 title claims abstract description 23
230000002255 enzymatic effect Effects 0.000 title claims abstract description 11
238000002360 preparation method Methods 0.000 title claims description 9
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 35
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 21
239000002028 Biomass Substances 0.000 claims abstract description 15
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 14
239000000872 buffer Substances 0.000 claims abstract description 12
241000194110 Bacillus sp. (in: Bacteria) Species 0.000 claims abstract description 9
229910019142 PO4 Inorganic materials 0.000 claims abstract description 9
239000010452 phosphate Substances 0.000 claims abstract description 9
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 9
239000004471 Glycine Substances 0.000 claims abstract description 7
238000006555 catalytic reaction Methods 0.000 claims abstract description 3
239000001963 growth medium Substances 0.000 claims abstract description 3
102000004190 Enzymes Human genes 0.000 claims description 16
108090000790 Enzymes Proteins 0.000 claims description 16
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
102000002260 Alkaline Phosphatase Human genes 0.000 claims description 8
108020004774 Alkaline Phosphatase Proteins 0.000 claims description 8
102000013563 Acid Phosphatase Human genes 0.000 claims description 6
108010051457 Acid Phosphatase Proteins 0.000 claims description 6
239000000706 filtrate Substances 0.000 claims description 5
GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 claims description 4
238000003756 stirring Methods 0.000 claims description 4
235000002595 Solanum tuberosum Nutrition 0.000 claims description 3
244000061456 Solanum tuberosum Species 0.000 claims description 3
244000309466 calf Species 0.000 claims description 3
210000000936 intestine Anatomy 0.000 claims description 3
239000002253 acid Substances 0.000 claims description 2
230000007515 enzymatic degradation Effects 0.000 claims description 2
150000001875 compounds Chemical class 0.000 claims 1
238000000605 extraction Methods 0.000 abstract description 4
238000004519 manufacturing process Methods 0.000 abstract description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
238000006243 chemical reaction Methods 0.000 description 12
239000000203 mixture Substances 0.000 description 10
PERZMHJGZKHNGU-JGYWJTCASA-N bambermycin Chemical compound O([C@H]1[C@H](NC(C)=O)[C@@H](O)[C@@H]([C@H](O1)CO[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1O[C@@H]([C@H]([C@H](O)[C@H]1NC(C)=O)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@H](O1)C(=O)NC=1C(CCC=1O)=O)O)C)[C@H]1[C@@H](OP(O)(=O)OC[C@@H](OC\C=C(/C)CC\C=C\C(C)(C)CCC(=C)C\C=C(/C)CCC=C(C)C)C(O)=O)O[C@H](C(O)=O)[C@@](C)(O)[C@@H]1OC(N)=O PERZMHJGZKHNGU-JGYWJTCASA-N 0.000 description 9
238000003776 cleavage reaction Methods 0.000 description 9
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
210000004027 cell Anatomy 0.000 description 8
230000007017 scission Effects 0.000 description 8
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
238000006731 degradation reaction Methods 0.000 description 6
235000021317 phosphate Nutrition 0.000 description 6
239000004181 Flavomycin Substances 0.000 description 5
230000015556 catabolic process Effects 0.000 description 5
235000019374 flavomycin Nutrition 0.000 description 5
239000002609 medium Substances 0.000 description 5
239000000243 solution Substances 0.000 description 5
239000002904 solvent Substances 0.000 description 5
239000000126 substance Substances 0.000 description 5
238000004809 thin layer chromatography Methods 0.000 description 5
239000003242 anti bacterial agent Substances 0.000 description 4
229940088710 antibiotic agent Drugs 0.000 description 4
238000004587 chromatography analysis Methods 0.000 description 4
239000000284 extract Substances 0.000 description 4
239000003208 petroleum Substances 0.000 description 4
239000000758 substrate Substances 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
241000193830 Bacillus <bacterium> Species 0.000 description 3
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
238000000855 fermentation Methods 0.000 description 3
230000004151 fermentation Effects 0.000 description 3
239000003112 inhibitor Substances 0.000 description 3
244000005700 microbiome Species 0.000 description 3
235000013343 vitamin Nutrition 0.000 description 3
239000011782 vitamin Substances 0.000 description 3
229940088594 vitamin Drugs 0.000 description 3
229930003231 vitamin Natural products 0.000 description 3
150000003722 vitamin derivatives Chemical class 0.000 description 3
238000005406 washing Methods 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
239000001888 Peptone Substances 0.000 description 2
108010080698 Peptones Proteins 0.000 description 2
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
230000003115 biocidal effect Effects 0.000 description 2
239000007795 chemical reaction product Substances 0.000 description 2
239000000287 crude extract Substances 0.000 description 2
239000007857 degradation product Substances 0.000 description 2
238000001514 detection method Methods 0.000 description 2
238000006911 enzymatic reaction Methods 0.000 description 2
238000002955 isolation Methods 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
239000012074 organic phase Substances 0.000 description 2
235000019319 peptone Nutrition 0.000 description 2
235000012015 potatoes Nutrition 0.000 description 2
239000000047 product Substances 0.000 description 2
238000000746 purification Methods 0.000 description 2
239000000741 silica gel Substances 0.000 description 2
229910002027 silica gel Inorganic materials 0.000 description 2
239000011734 sodium Substances 0.000 description 2
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
101710116957 D-alanyl-D-alanine carboxypeptidase Proteins 0.000 description 1
239000011665 D-biotin Substances 0.000 description 1
235000000638 D-biotin Nutrition 0.000 description 1
RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
230000005526 G1 to G0 transition Effects 0.000 description 1
229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
TYBWABJIIOVYOR-UHFFFAOYSA-N OCC(C(O)=O)OP(=O)=O Chemical compound OCC(C(O)=O)OP(=O)=O TYBWABJIIOVYOR-UHFFFAOYSA-N 0.000 description 1
108010013639 Peptidoglycan Proteins 0.000 description 1
229910000831 Steel Inorganic materials 0.000 description 1
JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
229930003779 Vitamin B12 Natural products 0.000 description 1
238000005273 aeration Methods 0.000 description 1
238000010564 aerobic fermentation Methods 0.000 description 1
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
229910052921 ammonium sulfate Inorganic materials 0.000 description 1
235000011130 ammonium sulphate Nutrition 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
150000001540 azides Chemical class 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
210000002421 cell wall Anatomy 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
RLGQACBPNDBWTB-UHFFFAOYSA-N cetyltrimethylammonium ion Chemical class CCCCCCCCCCCCCCCC[N+](C)(C)C RLGQACBPNDBWTB-UHFFFAOYSA-N 0.000 description 1
235000015165 citric acid Nutrition 0.000 description 1
AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
238000012258 culturing Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
238000004821 distillation Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
239000003480 eluent Substances 0.000 description 1
238000010828 elution Methods 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
229940050410 gluconate Drugs 0.000 description 1
239000000174 gluconic acid Substances 0.000 description 1
235000012208 gluconic acid Nutrition 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
238000011835 investigation Methods 0.000 description 1
RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
238000011031 large-scale manufacturing process Methods 0.000 description 1
244000144972 livestock Species 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
229960003512 nicotinic acid Drugs 0.000 description 1
235000001968 nicotinic acid Nutrition 0.000 description 1
239000011664 nicotinic acid Substances 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
238000013386 optimize process Methods 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229940014662 pantothenate Drugs 0.000 description 1
235000019161 pantothenic acid Nutrition 0.000 description 1
239000011713 pantothenic acid Substances 0.000 description 1
239000012071 phase Substances 0.000 description 1
229910000160 potassium phosphate Inorganic materials 0.000 description 1
239000008057 potassium phosphate buffer Substances 0.000 description 1
235000011009 potassium phosphates Nutrition 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
229960003581 pyridoxal Drugs 0.000 description 1
235000008164 pyridoxal Nutrition 0.000 description 1
239000011674 pyridoxal Substances 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
238000005185 salting out Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000000176 sodium gluconate Substances 0.000 description 1
235000012207 sodium gluconate Nutrition 0.000 description 1
229940005574 sodium gluconate Drugs 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000011877 solvent mixture Substances 0.000 description 1
238000010186 staining Methods 0.000 description 1
239000010959 steel Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
235000019157 thiamine Nutrition 0.000 description 1
KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
229960003495 thiamine Drugs 0.000 description 1
239000011721 thiamine Substances 0.000 description 1
238000005918 transglycosylation reaction Methods 0.000 description 1
238000005199 ultracentrifugation Methods 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
239000011715 vitamin B12 Substances 0.000 description 1
235000019163 vitamin B12 Nutrition 0.000 description 1
239000011592 zinc chloride Substances 0.000 description 1
235000005074 zinc chloride Nutrition 0.000 description 1
JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/60—Unsaturated compounds containing ether groups, groups, groups, or groups the non-carboxylic part of the ether being unsaturated

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Wood Science & Technology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Health & Medical Sciences (AREA)
General Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Enzymes And Modification Thereof (AREA)
Steroid Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IL10117292A 1991-03-08 1992-03-06 An enzymatic process for the preparation of AM from muanomycins IL101172A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4107460		1991-03-08

Publications (2)

Publication Number	Publication Date
IL101172A0 IL101172A0 (en)	1992-11-15
IL101172A true IL101172A (en)	1995-07-31

Family

ID=6426788

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL10117292A IL101172A (en)	1991-03-08	1992-03-06	An enzymatic process for the preparation of AM from muanomycins

Country Status (9)

Country	Link
EP (1)	EP0503419B1 (ja)
JP (1)	JPH04320692A (ja)
AT (1)	ATE155171T1 (ja)
CA (1)	CA2062446A1 (ja)
DE (1)	DE59208669D1 (ja)
DK (1)	DK0503419T3 (ja)
ES (1)	ES2104751T3 (ja)
GR (1)	GR3024178T3 (ja)
IL (1)	IL101172A (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0652205A3 (de) *	1993-11-04	1995-08-30	Hoechst Ag	Moenomycin-Abbauprodukte mit hydroxylierter oder oxidierter Lipidseitenkette und Moenomycin-Analoga, ein Verfahren zur Herstellung und die Verwendung dieser Verbindungen.
RU2204597C2 (ru) *	2001-03-05	2003-05-20	Филенков Владимир Михайлович	Штамм архебактерий bacillus sp. вкпм в-5061 - деструктор нефтепродуктов и фосфатов, используемый при очистке почвы и сточных вод

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1068639A (en) *	1964-09-21	1967-05-10	Hoechst Ag	A purified form of the antibiotic moenomycin and a process for its manufacture
EP0355679B1 (de) *	1988-08-20	1996-02-28	Hoechst Aktiengesellschaft	Neuer Mikroorganismus zum Abbau von Moenomycinen, Verfahren zum Abbau sowie die Verwendung der Abbauprodukte

1992
- 1992-03-02 DE DE59208669T patent/DE59208669D1/de not_active Expired - Fee Related
- 1992-03-02 ES ES92103534T patent/ES2104751T3/es not_active Expired - Lifetime
- 1992-03-02 AT AT92103534T patent/ATE155171T1/de not_active IP Right Cessation
- 1992-03-02 DK DK92103534.1T patent/DK0503419T3/da active
- 1992-03-02 EP EP92103534A patent/EP0503419B1/de not_active Expired - Lifetime
- 1992-03-06 CA CA002062446A patent/CA2062446A1/en not_active Abandoned
- 1992-03-06 JP JP4048992A patent/JPH04320692A/ja active Pending
- 1992-03-06 IL IL10117292A patent/IL101172A/en not_active IP Right Cessation
1997
- 1997-07-22 GR GR970401823T patent/GR3024178T3/el unknown

Also Published As

Publication number	Publication date
GR3024178T3 (en)	1997-10-31
CA2062446A1 (en)	1992-09-09
JPH04320692A (ja)	1992-11-11
DK0503419T3 (da)	1998-02-02
ATE155171T1 (de)	1997-07-15
IL101172A0 (en)	1992-11-15
EP0503419A1 (de)	1992-09-16
ES2104751T3 (es)	1997-10-16
EP0503419B1 (de)	1997-07-09
DE59208669D1 (de)	1997-08-14

Legal Events

Date	Code	Title	Description
1998-08-16	KB	Patent renewed
2002-12-01	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
JP3233476B2 (ja)	2001-11-26	Ｆｏ−１２８９物質およびその製造法
US20170260495A1 (en)	2017-09-14	An amycolatopsis sp. strain and methods of using the same for vanillin production
US5179013A (en)	1993-01-12	Cytochrome P-450 enzymes
US5468625A (en)	1995-11-21	α-L-Rhamnosidase for obtaining rhamnose, a process for its preparation and its use
US4774179A (en)	1988-09-27	Process for preparing a 7-aminocephalosporanic acid compound
DK165191B (da)	1992-10-19	L-carnitin-producerende mikroorganismer samt fremgangsmaade til fremstilling af l-carnitin under anvendelse af mikroorganismerne
EP0044736A2 (en)	1982-01-27	Process for the preparation of deacetylcephalosporin C
US5316929A (en)	1994-05-31	Process for the preparation of MA
US5206405A (en)	1993-04-27	2-alkenyloxy-3-(phosphono)oxypropanoic acids derived from the cleavage of phosphoglycolipid antibiotics
US5506140A (en)	1996-04-09	Bacillus strain for breaking down moenomycins
US5315038A (en)	1994-05-24	Microorganism for breaking down moenomycins, a process for the breakdown, and the use of the breakdown products
US5260206A (en)	1993-11-09	Enzymes for breaking down moenomycins
US4248967A (en)	1981-02-03	Enzymic complexes adapted to convert racemic hydantoins into optically active aminoacids, and their applications
JP2863557B2 (ja)	1999-03-03	新規なモエノマイシン分解微生物および分解方法
CA2062446A1 (en)	1992-09-09	Process for the preparation of ma
IE870339L (en)	1987-08-11	Products of l-sorbose
KOMURA et al.	1985	Biosynthesis of polymyxin E by a cell-free enzyme system: IV. acylation of enzyme-bound L-2, 4-Diaminobutyric acid
CA1193211A (en)	1985-09-10	Process for producing mitomycin a by fermentation
CZ283529B6 (cs)	1998-04-15	Použití gama-glutamyltranspeptidázy pro hydrolýzu alfa-aminoadipinylmonoaminosloučenin
GB2174696A (en)	1986-11-12	Cyclic adenosine-3',5'-monophosphate phosphodiesterase inhibitors
EP0046641A2 (en)	1982-03-03	Novel antibiotics, the microbiological preparation of antibiotics, and a novel microorganism
EP0216636A2 (en)	1987-04-01	Process for producing oganomycin E
WO1992018637A1 (en)	1992-10-29	Method for the production of d-gluconic acid
KR100260837B1 (ko)	2000-07-01	광학활성 카본산 및 그 거울상 이성체 에스테르의 제조방법
JPH07241197A (ja)	1995-09-19	２５−ヒドロキシビタミンｄ類の製造法